Vasocure
Healthcare
The world's first drug to treat neointimal disease
Vasocure is a clinical-stage nephrology therapeutics company with the world's first peptide to directly treat neointimal hyperplasia, or neointimal disease, arteriosclerosis, and atherosclerosis. Learn more at vasocuretherapeutics.com.
As their creative partner, we provided:
Logo design
Behind the scenes
Video shoot and photography session at our New York City office.
Ready to get started?
Join GDS Monthly and let us take care of your content so you can focus on what’s next.
Sign up to our newsletter
